Anti-IL17A重组抗体|科研级 Ixekizumab ( 伊卡组单抗 )-Product Center-Tekbiotech-Yeast and Phage Display CRO, Expert in Nano-body and Antibody Drug Development

Anti-IL17A重组抗体|科研级 Ixekizumab ( 伊卡组单抗 )

Detailed related information Target background information Experimental Plan&FAQ Related products Recommended Services

询价与订购

Name*
Phone*
Email*
Product*
Content*

Anti-IL17A重组抗体|科研级 Ixekizumab ( 伊卡组单抗 )

instructions Contact

< >

CatNo：TKYR1008

Price

WeChat QR
Contact Us

instructions
MSDSWeChat QR
Contact Us

Detailed

Background

Plan&FAQ

Recommended

Detailed related information

Catalog Number

TKYR1008

Alias

科研级 Ixekizumab ( 伊卡组单抗 ), Anti-IL17A Recombinant Antibody, Research Grade Ixekizumab

Molecular Name

Ixekizumab

Size

1mg, 5mg

CAS Number

1143503-69-8

Isotype

IgG4 Kappa

Clonality

Monoclonal

Concentration

1mg/ml

Molecular Weight

146.16 kDa

Applications

WB, IP, IF, FuncS, FC, Neut, ELISA

Source

CHO Cells

Purity

≥95% as determined by SDS-PAGE

Buffer

Supplied in PBS, PH7.5

Protein Chemical Formula

C6492H10012N1728O2028S46

Target

IL17A [Homo sapiens]

Sequence

Please contact our sales representative to learn more information about this reagents.

Background

Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized monoclonal antibody.[5] The substance acts by binding interleukin 17A and neutralizing it, reducing inflammation.

Storage

该产品可在 2°C-8°C 下保存一个月，活性不会明显降低。在 -20°C 至 -80°C 下保存，可稳定保存十二个月。避免反复冻融,用冰袋运输。

NOTE

仅科研使用

Target background information

Experimental Plan&FAQ